Using cutting edge sequencing and genotyping technology, genes causing common and rare human diseases will be identified, and genetic methods developed to diagnose genetic diseases in both antenatal and postnatal life. Treatments for common rheumatic diseases affecting tens of thousands of Australians will be developed informed by these genetic findings.
Solving The Causes Of And Development Of New Therapies For Ankylosing Spondylitis And Related Diseases
Funder
National Health and Medical Research Council
Funding Amount
$863,910.00
Summary
Ankylosing spondylitis (AS) is a highly heritable and common form of arthritis affecting primarily the spine and pelvis, and is the 2nd most common form of arthritis worldwide (~0.55%). In this fellowship I will extend my world-leading program of AS research by increasing understanding of its basic causes through research into its genetic and environmental triggers, and from this develop new treatments for this and related diseases such as psoriasis and inflammatory bowel disease.
Developing And Applying Statistical Genetics Methods To Identify Genes, Molecular Biomarkers And Environmental Agents That Causally Affect Risk Of Complex Musculoskeletal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$707,370.00
Summary
My aim is to identify genes, biological molecules and environmental factors that causally affect risk of osteoporosis and ankylosing spondylitis (a form of autoimmune arthritis) using novel and existing statistical genetics methodologies. My research will advance understanding of the causes of these diseases, identify new opportunities for their treatment, and provide the scientific community with new statistical methods and software to identify factors that causally influence risk of disease.
Elimination Of Zoonotic Schistosomiasis And Echinococcosis Through Integrated Morbidity Control
Funder
National Health and Medical Research Council
Funding Amount
$898,008.00
Summary
I am a parasitologist researching the biology, immunology and epidemiology of human parasitic worms, particularly the schistosome bloodflukes and the hydatid tapeworms, which cause bilharzia and hydatidosis, diseases of the world’s poorest people that cause both major suffering and economic loss. My goal is to develop new methods, including vaccination, to control and eventually eliminate these parasites.
Immunological Prevention Of Cysticercosis And Hydatid Disease
Funder
National Health and Medical Research Council
Funding Amount
$802,685.00
Summary
Professor Lightowlers’ has developed the world’s most effective vaccines against diseases caused by parasites. The vaccines prevent transmission of parasites from livestock animals to humans. During the next 5 years the vaccines will be produced on a large scale and evaluated in field trials. The products of this research program will make a major contribution to reducing the number of people suffering from parasitic cysts.
Therapeutic And Diagnostic Approaches For The Neurodegenerative Diseases
Funder
National Health and Medical Research Council
Funding Amount
$804,106.00
Summary
Diseases of the brain such as Alzheimer’s and Parkinson’s disease cause enormous socio-economic harm to Australia. They are a major cause of disability and the burden associated with mental illness is predicted to grow by almost 50% over the coming decade. Therefore there is an urgent need to develop new approaches to identify and treat these diseases. This Fellowship will be dedicated to creating new diagnostic methods and treatments for these diseases
Exploration Of The Role Of Microbes In Gastrointestinal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$687,974.00
Summary
This fellowship will investigate diseases of the gastrointestinal tract of children. The research program will undertake a range of is a highly innovative projects including; development of an effective rotavirus vaccine to be administered to newborns; genetic characterisation of rotavirus strains able to escape vaccine protection; and how alterations in the human gut microbiome (bacteria and viruses) influence the development/relapse of CrohnÍs disease.
Exploiting Existing Data Sources To Improve The Prevention And Treatment Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
My program of research exploits several large databases to answer important issues in the prevention and treatment of cardiovascular disease (CVD), which makes a huge contribution to the burden of illness and premature mortality in Australia. An underlying aim is to provide the evidence base to facilitate improvement of the existing CVD risk assessment guidelines in Australia, for better targeting of clinical advice and treatment.
Identifying Novel Targets To Treat And Prevent Diabetic Complications
Funder
National Health and Medical Research Council
Funding Amount
$697,209.00
Summary
Diabetes is the leading cause for kidney failure requiring dialysis or transplantation. Diabetic patients also have a higher risk to suffer from heart attacks, stroke and amputations in particular once kidney damage occurs. Current strategies fail to completely protect patients from complications. My research will uncover knowledge gaps in our understanding of diabetes complications, identify new targets ultimately leading to urgently needed more effective treatments and prevention strategies to ....Diabetes is the leading cause for kidney failure requiring dialysis or transplantation. Diabetic patients also have a higher risk to suffer from heart attacks, stroke and amputations in particular once kidney damage occurs. Current strategies fail to completely protect patients from complications. My research will uncover knowledge gaps in our understanding of diabetes complications, identify new targets ultimately leading to urgently needed more effective treatments and prevention strategies to reduce the burden of disease in diabetes.Read moreRead less
Although the major risk factors for cardiovascular diseases have been known for decades, and modern-day treatment is much advanced, the importance of these diseases persists, such that they remain the number one killer in Australia. This suggests that more can be done to correctly identify those at high and moderate risk of future disease, so as to optimize advice and medical treatment. This project will use the best evidence available to develop new methods of risk prediction and prevention.